News Formal

Psychedelics company ATAI raises $125 million Series C funding round - Business Insider

  • 📰 BusinessInsider
  • ⏱ Reading Time:
  • 20 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 11%
  • Publisher: 51%

Sverige Nyheter Nyheter

Sverige Senaste nytt,Sverige Rubriker

A major psychedelics company just landed a record sum of cash from VCs. The CEO told us how he raised the mega-round and why it's a sign psychedelics are going mainstream.

In this Friday, May 24, 2019 photo a vendor bags psilocybin mushrooms at a pop-up cannabis market in Los Angeles.ATAI Life Sciences closed a $125 million Series C round, marking the biggest funding round to date in the psychedelics space.

ATAI invests in and acquires companies looking to develop medicines for mental-health conditions from psychedelics like psilocybin, arketamine, and ibogaine. The round announced Monday came from investors including Thiel, Galaxy, Falcon Edge Capital, Catalio Capital Management, and ATAI founder Christian Angermayer's family office Apeiron Investment Group.The CEO of a $1.

 

Tack för din kommentar. Din kommentar kommer att publiceras efter att ha granskats.

wow

Vi har sammanfattat den här nyheten så att du kan läsa den snabbt. Om du är intresserad av nyheterna kan du läsa hela texten här. Läs mer:

 /  🏆 729. in SE

Sverige Senaste nytt, Sverige Rubriker